| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3028832 | Thrombosis Research | 2007 | 7 Pages |
Abstract
Our results demonstrate that raloxifene and continuous combined hormone therapy exhibit the same prothrombotic profile. Both treatments induced an increase in procoagulant parameters at 6 months and a decrease in anticoagulant parameters at 12 months.
Keywords
SERMFVIIHRTFVIIIAPCRF1 + 2antithrombinCoagulationPAIplasminogen activator inhibitorTATD-dimerRaloxifenebody mass indexBMIFactor VIIIFactor VFactor VIIactivated protein C resistanceThrombin–antithrombin complexSelective estrogen receptor modulatorfollicle-stimulating hormonehormone replacement therapyFSHProtein CProtein SMenopause
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Mariapaola Sgarabotto, Monica Baldini, Alessandra Dei Cas, Cesare Manotti, Angela Luciana Barilli, Maurizio Rinaldi, Luigi Benassi, Alberto Bacchi Modena,